相关实验视频
Updated: Jun 28, 2026

06:08
Quantification of Hypopigmentation Activity In Vitro
Published on: March 6, 2019
11.8K
[韩国2023-2024赛季流感疫苗接种计划]
Seohyeon Ahn1, Wookeon Lee1, Hyewook Hwang1
1질병관리청 의료안전예방국 예방접종관리과.
Jugan geon-gang gwa jilbyeong
|December 3, 2025
概括
在2023-2024年国家流感疫苗接种计划中,老年人和孕妇的疫苗接种率增加,但儿童的疫苗接种率下降. 不良事件很少发生,这表明安全的流感免疫计划.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 免疫接种计划 免疫接种计划
背景情况:
- 国家流感疫苗接种计划对于减轻流感影响至关重要.
- 目标人群包括儿童,孕妇和老年人.
- 监测疫苗接种覆盖率和结果对于计划的有效性至关重要.
研究的目的:
- 分析2023-2024年国家流感疫苗接种计划的主要结果.
- 评估关键人口群体的疫苗接种率.
- 报告接种流感疫苗后的不良事件.
主要方法:
- 对2023-2024赛季全国流感疫苗接种数据的回顾性分析.
- 计算儿童 (6个月-13岁),孕妇和老年人 (65岁以上) 的疫苗接种率.
- 免疫接种后报告的不良事件的分析.
主要成果:
- 疫苗接种率:老年人82.5% (增长0.6%),孕妇53.0% (增长2.6%),儿童69.5% (下降1.5%). 疫苗接种率:老年人82.5% (增长0.6%),孕妇53.0% (增长2.6%),儿童69.5% (下降1.5%). 疫苗接种率:老年人82.5% (增长0.6%),孕妇53.0% (增长2.6%),儿童69.5% (下降1.5%). 疫苗接种率:老年人82.5% (增长0.6%),孕妇53.0% (增长2.6%),儿童69.5% (下降1.5%).
- 副作用:报告了176例病例,相当于每10万次接种疫苗就有1.5例.
- 趋势表明,成年人免疫接种率有所改善,但儿童流感免疫接种率有所下降.
结论:
- 2023-2024年计划的结果不一,老年人和孕妇的覆盖率增加,儿童的覆盖率下降.
- 流感疫苗接种仍然是一个安全的干预措施,不良反应的发生率很低.
- 研究结果为未来的策略提供了基础,以加强国家流感免疫工作,特别是儿童群体.
更多相关视频
08:58Label-Free Identification of Lymphocyte Subtypes Using Three-Dimensional Quantitative Phase Imaging and Machine Learning
Published on: November 19, 2018
13.0K
08:34Field-Deployable Lens-Free Imaging Platform for Rapid Label-Free Analysis of Natural Killer Cell Activation
Published on: August 8, 2025
1.7K
相关概念视频
Vaccinations
Overview
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Infectious Diseases and Their Occurrence
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...